针对可调节的纳米载体相互作用,物理化学性质和未来的纳米载体的审查
Sonia Pandey1, Shrikant Joshi2, Purnima Tripathi3
1Department of Pharmacy, Yashraj College of Professional Studies, Kanpur, U.P. 209217, India.
概括
纳米技术通过优化纳米载体特性来提高药物输送,从而提高针对性治疗的效果. 了解这些物理化学因素是提高治疗效率和减少副作用的关键,特别是在癌症治疗中.
科学领域:
- 纳米医学是一种纳米医学.
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
背景情况:
- 使用纳米技术的向药物递送提供了更好的疗效和减少副作用.
- 纳米载体的物理化学特性 (大小,形状,电荷,弹性) 决定了生物相互作用和向.
- 进步包括智能纳米载体对刺激做出反应,以控制药物释放.
研究的目的:
- 从2015年至2025年,审查纳米载体设计的进展,以针对癌症特定的向.
- 分析关键参数,以选择合适的纳米载体临床转化方法.
- 讨论针对性纳米药物输送系统的挑战.
主要方法:
- 文献综述综合纳米载体设计和准策略的研究.
- 对影响纳米载体性能的物理化学性质的分析.
- 讨论当前的准方法和未来的挑战.
主要成果:
- 物理化学性质对于纳米载体导航,免疫逃避和目标积累至关重要.
- 智能材料和表面修改增强了准特异性和受控释放.
- 挑战包括蛋白质冠状,瘤微环境和生物障碍.
结论:
- 优化纳米载体的物理化学性质对于有效的向药物输送至关重要.
- 对于临床翻译,需要进一步研究准方法和克服生物障碍.
- 纳米技术具有革命性癌症治疗的巨大潜力.
更多相关视频
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
7.7K
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
2.0K
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
114
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
114